127 related articles for article (PubMed ID: 35638238)
1. Long-Term Outcomes in Head and Neck Paragangliomas Managed with Intensity-Modulated Radiotherapy.
Rougier G; Rochand A; Bourdais R; Meillan N; Tankere F; Herman P; Riet F; Mazeron JJ; Burnichon N; Lussey-Lepoutre C; Jacob J; Simon JM; Maingon P; Feuvret L
Laryngoscope; 2023 Mar; 133(3):607-614. PubMed ID: 35638238
[TBL] [Abstract][Full Text] [Related]
2. Long-term Outcomes for the Treatment of Paragangliomas in the Upfront, Adjuvant, and Salvage Settings With Stereotactic Radiosurgery and Intensity-modulated Radiotherapy.
Anderson JL; Khattab MH; Anderson C; Sherry AD; Luo G; Manzoor N; Attia A; Netterville J; Cmelak AJ
Otol Neurotol; 2020 Jan; 41(1):133-140. PubMed ID: 31789966
[TBL] [Abstract][Full Text] [Related]
3. Treatment of head and neck paragangliomas with external beam radiation therapy.
Dupin C; Lang P; Dessard-Diana B; Simon JM; Cuenca X; Mazeron JJ; Feuvret L
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):353-9. PubMed ID: 24685154
[TBL] [Abstract][Full Text] [Related]
4. Protontherapy of head and neck paragangliomas: A monocentric study.
Cao KI; Feuvret L; Herman P; Bolle S; Jouffroy T; Goudjil F; Amessis M; Rodriguez J; Dendale R; Calugaru V
Cancer Radiother; 2018 Feb; 22(1):31-37. PubMed ID: 29269165
[TBL] [Abstract][Full Text] [Related]
5. Head and neck paragangliomas: Experience in 126 patients with 162 tumours.
González-Orús Álvarez-Morujo RJ; Arístegui Ruiz MÁ; da Costa Belisario J; Martinez Guirado T; Scola Yurrita B
Acta Otorrinolaringol Esp; 2015; 66(6):332-41. PubMed ID: 25638014
[TBL] [Abstract][Full Text] [Related]
6. Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
Chen AM; Daly ME; Farwell DG; Vazquez E; Courquin J; Lau DH; Purdy JA
JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):129-33. PubMed ID: 24337483
[TBL] [Abstract][Full Text] [Related]
7. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
8. Definitive radiotherapy in the management of paragangliomas arising in the head and neck: a 35-year experience.
Hinerman RW; Amdur RJ; Morris CG; Kirwan J; Mendenhall WM
Head Neck; 2008 Nov; 30(11):1431-8. PubMed ID: 18704974
[TBL] [Abstract][Full Text] [Related]
9. Costs of care in a matched pair comparison of intensity-modulated radiation therapy (IMRT) versus conventional radiation therapy (CRT) for the treatment of head and neck cancer.
Sheets NC; Wheeler SB; Kohler RE; Fried DV; Brown PM; Chera BS
Am J Clin Oncol; 2014 Dec; 37(6):539-44. PubMed ID: 23466583
[TBL] [Abstract][Full Text] [Related]
10. Paraganglioma of the head and neck: long-term local control with radiotherapy.
Chino JP; Sampson JH; Tucci DL; Brizel DM; Kirkpatrick JP
Am J Clin Oncol; 2009 Jun; 32(3):304-7. PubMed ID: 19433962
[TBL] [Abstract][Full Text] [Related]
11. Paragangliomas of the Head and Neck: Local Control and Functional Outcome Following Fractionated Stereotactic Radiotherapy.
Weissmann T; Lettmaier S; Roesch J; Mengling V; Bert C; Iro H; Hornung J; Janka R; Semrau S; Fietkau R; Putz F
Am J Clin Oncol; 2019 Nov; 42(11):818-823. PubMed ID: 31592806
[TBL] [Abstract][Full Text] [Related]
12. Acute toxicity in comprehensive head and neck radiation for nasopharynx and paranasal sinus cancers: cohort comparison of 3D conformal proton therapy and intensity modulated radiation therapy.
McDonald MW; Liu Y; Moore MG; Johnstone PA
Radiat Oncol; 2016 Feb; 11():32. PubMed ID: 26922239
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience.
Van Gestel D; Van Den Weyngaert D; Schrijvers D; Weyler J; Vermorken JB
Br J Radiol; 2011 Apr; 84(1000):367-74. PubMed ID: 21415302
[TBL] [Abstract][Full Text] [Related]
14. [Paraganglioma of the head and neck--tumor control, functional results and quality of life].
Kollert M; Minovi A; Mangold R; Hendus J; Draf W; Bockmühl U
Laryngorhinootologie; 2006 Sep; 85(9):649-56. PubMed ID: 16612748
[TBL] [Abstract][Full Text] [Related]
15. Limited Toxicity of Hypofractionated Intensity Modulated Radiation Therapy for Head and Neck Cancer.
Mayo ZS; Ilori EO; Matia B; Smile TD; Fleming CW; Reddy CA; Scharpf J; Lamarre ED; Prendes BL; Ku J; Burkey BB; Joshi NP; Woody NM; Koyfman SA; Campbell SR
Anticancer Res; 2022 Apr; 42(4):1845-1849. PubMed ID: 35347002
[TBL] [Abstract][Full Text] [Related]
16. A two-decade experience of head and neck paragangliomas in a whole population-based single centre cohort.
Anttila T; Häyry V; Nicoli T; Hagström J; Aittomäki K; Vikatmaa P; Niemelä M; Saarilahti K; Mäkitie A; Bäck LJ
Eur Arch Otorhinolaryngol; 2015 Aug; 272(8):2045-53. PubMed ID: 24973967
[TBL] [Abstract][Full Text] [Related]
17. Malignant head/neck paragangliomas. Comparative study.
Mediouni A; Ammari S; Wassef M; Gimenez-Roqueplo AP; Laredo JD; Duet M; Tran Ba Huy P; Oker N
Eur Ann Otorhinolaryngol Head Neck Dis; 2014 Jun; 131(3):159-66. PubMed ID: 24239180
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
19. Comparison three-dimensional conformal radiotherapy versus intensity modulated radiation therapy in local control of head and neck cancer.
Ghosh G; Gupta G; Malviya A; Saroj D
J Cancer Res Ther; 2018; 14(6):1412-1417. PubMed ID: 30488865
[TBL] [Abstract][Full Text] [Related]
20. Using Image-guided Intensity-modulated Radiotherapy on Patients With Head and Neck Soft-tissue Sarcoma.
Elsayad K; Stockmann D; Channaoui M; Scobioala S; Grajda A; Berssenbrügge H; Huss S; Moustakis C; Haverkamp U; Kleinheinz J; Lenz G; Wardelmann E; Eich HT
In Vivo; 2019; 33(4):1293-1300. PubMed ID: 31280221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
